Ann: AGM Presentation, page-47

Why would one consider this hype - there is actually some substance as if the data is accepted by the industry, it will no doubt lead to partnerships with commercialisation opportunities. This would then result in a substantial rerate leading into the next phase. Why? Because ultimate realisation makes bit a multi billion dollar company. However we all acknowledge more hurdles need to be overcome. However leading up to it the sp will keep progressing over time to reflect the potential. So 400-500 million mc is not unreasonable for a company that is targeting a space that involves 12 b and another mega billion market space ( don’t forget the hep) as this can act as a platform to target other virus. In south east Asia alone dengue treatment ( which as no cure at the moment) will result in an ongoing bonanza not to mention the other cruel viruses that can debilitate.